/2561 November 12, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q3/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
: Management discussion and analysis for the period three-month ended September 30, 2018 To Director and Manager of the Stock Exchange of Thailand Referring to the submission of the reviewed financial statements
: President of the Stock Exchange of Thailand Seamico Securities Public Company Limited and its subsidiaries (“The Company”) would like to report operating result that has been reviewed by our auditor for the
ที่ หทว No. Kor Bor Ror. 018/2018 November 12, 2018 President The Stock Exchange of Thailand Re : Entering transactions with connected parties for 2019 Dear Sir, Thai Wacoal Public Company Limited
ที่ กบร No. Kor Bor Ror. 019/2018 November 12, 2018 President The Stock Exchange of Thailand Re : Inter-transaction of purchasing assets by subsidiary companies, and transaction of subsidiary company
/4 Ref: J61/011 12 November 2018 Subject: Management Discussion and Analysis, 3rd Quarter Ending 30 September 2018 To: President The Stock Exchange of Thailand Regarding to JAS Asset Public Company
exceed 20% To : The President The Stock Exchange of Thailand Bangkok Chain Hospital Public Company Limited (the “Company”) would like to report the operating results of the Company and its subsidiaries for
President and Director The Stock Exchange of Thailand Dear Sirs, Finansia Syrus Securities Public Company would like to disclose the reviewed separated and consolidated financial statements for the nine-month
(มหำชน) Food and Drinks Public Company Limited 1 | P a g e November 13, 2018 Subject: Management discussion and analysis of the operating results for the quarter 3/2018 Attn: President The Stock
exceed 20% (Revised) To : The President The Stock Exchange of Thailand Bangkok Chain Hospital Public Company Limited (the “Company”) would like to report the operating results of the Company and its